BIG PHARMA EARNINGS WATCH: NOVARTIS & GSK
Oct 30, 2026
Big Pharma Giants Beat Wall Street Expectations Following Price Hikes,… Read More
© 2026 CSRXP- All Rights Reserved
Updates
BIG PHARMA EARNINGS WATCH: ROCHE
Oct 23, 2026
Roche Tops Wall Street Expectations Following Price Hikes, Executives… Read More
DOSE OF REALITY: NEW ICER REPORT FINDS BIG PHARMA’S LAUNCH PRICES REMAIN OUT OF CONTROL AND UNJUSTIFIED BY CLINICAL VALUE
Oct 21, 2026
Median Net Launch Prices Have Increased 35 Percent Since 2022… Read More
THEY SAID IT! R STREET CALLS FOR BIPARTISAN, MARKET-BASED SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Oct 14, 2026
Article Highlights How Congress Can Address Patent Thickets, Product Hopping… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 14, 2026
Big Pharma Giant Beats Earnings, Projects $100 Billion in Annual Sales… Read More
DOSE OF REALITY: JAMA STUDY FINDS DRUG PATENT PORTFOLIOS ON SMALL MOLECULE DRUGS HAVE MORE THAN TRIPLED, DELAYING GENERIC COMPETITION
Sep 30, 2026
New Analysis Shows Brand Name Drug Companies Increasingly Rely On Follow-On… Read More
DOSE OF REALITY: AARP ANALYSIS EXAMINES PATENT ABUSE ON BRAND NAME INHALER THAT KEPT PRICES HIGH FOR PATIENTS
Sep 30, 2026
Report Details How Tactics Like Patent Thicketing and Product Hopping Delayed… Read More
DOSE OF REALITY: BIOSIMILAR SLOWDOWN UNDERSCORES URGENCY FOR SOLUTIONS TO FOSTER GREATER COMPETITION, ENCOURAGE BIOSIMILAR DEVELOPMENT
Sep 16, 2026
Congress Should Pass Bipartisan, Market-Based Solutions to Reduce Unnecessary… Read More
ICYMI: NEW CSRxP ANALYSIS FINDS BIG PHARMA SPENDS THREE TIMES MORE ON PROFITS, ADVERTISING AND OVERHEAD THAN R&D
Sep 9, 2026
“Big Pharma Dollar” Analysis Shows Brand Name Pharmaceutical… Read More
NEW CSRxP ANALYSIS: BIG PHARMA SPENDS THREE TIMES MORE ON PROFITS, ADVERTISING AND OVERHEAD THAN R&D
Sep 2, 2026
Breaking Down The “Big Pharma Dollar” Shows Brand Name Pharmaceutical… Read More
CSRxP: BIG PHARMA HIKES PRICES ON NEARLY 250 PRESCRIPTION DRUGS IN LATEST ROUND OF MID-YEAR PRICE HIKES
Aug 25, 2026
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY & NOVO NORDISK
Aug 21, 2026
Big Pharma Giants Smash Second Quarter Earnings After Price Hikes Across Their… Read More